A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 19:45
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.

You Might Like...

Get a lifetime license to Microsoft Office for under £40

Elon Musk’s Neuralink brain chip company says it now has FDA approval for human testing

Tristan Tate hails 'JRE' podcast featuring Patrick Bet-David, fans say 'get your popcorn ready folks'

Factbox-Why does the US want to ban TikTok? The allegations against it

What Happened to Apex Legends Mobile?

We’ve found a PS5 deal in the Amazon Prime Day sale, and it’s sure to sell out

LEGO Launches a New Line of Braille Bricks

Soon, you'll have to pay to DM people who don't follow you on Twitter